Collaborations

The path from scientific breakthrough to successful biopharmaceutical brand depends on mobilizing the best resources, expertise and experience.

At Avanti, we often achieve success through close collaboration with partners who share a common vision and complementary strengths. A key Avanti priority is to build winning collaborations in the research of innovative use of technology to develop and commercialize novel personalized diagnostics, medicines and vaccines.

Visit www.germinate.at-gc.com

for more information Avanti Therapeutics'  entrepreneurial ecosystem.

 

Our collaboration process

Avanti has structured a streamlined collaboration process to provide rapid evaluation of potential opportunities, with the early involvement of senior management. Key elements of our collaboration process:

• A single gateway for all opportunities to facilitate initial contact and subsequent coordination of the evaluation process
• Standard review criteria, comprising evaluation of the scientific basis of the opportunity, market potential and commercial viability
• Standard review and decision-making process driven by Business Development and Licensing (BD&L)

If you have a pharmaceutical product or business opportunity, please contact our business development team member.

Areas of Interest

We are actively seeking partnerships in several therapeutic areas. Please explore your area of interest.

• Oncology  
• Cardiovascular  
• Immunology and Infectious Diseases
• Neuroscience
• Regenerative Medicine
• Molecular Diagnostics

For other inquiries, please contact:

 

Avanti Therapeutics Business Development & Licensing